| MASH/NASH | non-alcoholic steatohepatitis |
| MAFLD/NAFLD | non-alcoholic fatty liver disease |
| T2DM | type 2 diabetes mellitus |
| PKA | protein kinase A |
| PI3K | phosphatidylinositol-3-kinase |
| AKT/PKB | protein Kinase B |
| AMPK | adenosine 5‘-monophosphate (AMP)-activated protein kinase |
| MAPK | mitogen-activated protein kinase |
| PPARγ | peroxisome proliferator-activated receptor γ |
| FABP4 | fatty acid-binding protein 4 |
| BMP4 | bone morphogenetic protein 4 |
| UCP1 | uncoupling protein 1 |
| ARC | activity-regulated cytoskeleton-associated protein |
| AgRP | agouti-related protein |
| NPY | neuropeptide Y |
| GIP | gastric inhibitory polypeptide |
| GIPR | gastric inhibitory polypeptide receptor |
| GCG | glucagon |
| GCGR | glucagon receptor |
| NTS | nucleus tractus solitarius |
| AOM | azoxymethane |
| FDA | food and drug administration |
| TAG | triacylglycerol |
| WAT | white adipose tissue |
| HbA1c | glycosylated hemoglobin, type A1C |
| CCK | cholecystokinin |
| PYY | peptide YY |
| mTOR | mammalian target of rapamycin |
| mTORC1 | mechanistic target of rapamycin complex 1 |
| mTORC2 | mechanistic target of rapamycin complex 2 |
| GLUT4 | glucose transporter 4 |
| GSK3 | glycogen synthase kinase-3 |
| MAPKKK | mitogen-activated protein kinase kinase kinase |
| BAT | brown adipose tissue |
| p38-MAPK | p38 mitogen-activated protein kinase |
| ERK | extracellular signal-related kinases |
| ERK5 | extracellular signal-related kinases 5 |
| ERK1/2 | extracellular signal-related kinases 1/2 |
| TCF | transcription factor |
| C1EBPα/CCAAT | enhancer-binding proteins |
| ADD1 | adducin 1 |
| APM | acute poliomyelitis |
| GSK3β | glycogen synthase kinase 3 β |
| OSBPL2 | oxysterol binding protein-like 2 |
| CXXC5 | CXXC finger protein 5 |
| NOTUM | notum palmitoleoyl-protein carboxylesterase |